BioMark Diagnostics Inc.
BUX
Clasificación en acciones
#26672
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Precio por acción
$0.33433516
Última sincronización: 2026-10-20
Capitalización bursátil
$35.60M
Cambio (1 día)
-3.08%
Cambio (1 año)
39.31%
País
CA
Comercio BioMark Diagnostics Inc. (BUX)
Categoría
Healthcare
Historial del precio de la acción de BioMark Diagnostics Inc. (BUX)
Precio más alto de cierre: $0.38 el 2026-10-01
Precio más bajo de cierre: $0.35 el 2015-03-01
Precio más bajo de cierre: $0.35 el 2015-03-01
Historial del precio de la acción de BioMark Diagnostics Inc. desde 2015 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | 6.88% |
| 2025 | 136.71% |
| 2024 | -19.87% |
| 2023 | 29.58% |
| 2022 | -34.72% |
| 2021 | 122.09% |
| 2020 | -51.07% |
| 2019 | 376.19% |
| 2018 | -44.93% |
| 2017 | -9.77% |
| 2016 | -22.98% |
| 2015 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.25 | 50.06% |
CN
|
|
| $177.93 | 21.98% |
US
|
